Respiratory System Benign Neoplasm disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Respiratory System Benign Neoplasm

MalaCards integrated aliases for Respiratory System Benign Neoplasm:

Name: Respiratory System Benign Neoplasm ¹¹ ¹⁴

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Respiratory diseases

See all MalaCards categories (disease lists)

ICD10: ³¹

Neoplasms

Benign neoplasms

Benign neoplasm of middle ear and respiratory system

Benign neoplasm: Respiratory system, unspecified

External Ids:

Disease Ontology ¹¹ DOID:0050621

ICD10 ³¹ D14.4

Sources

Summaries for Respiratory System Benign Neoplasm

Disease Ontology: ¹¹ An organ system benign neoplasm that is located in the respiratory system which extends from the nasal sinuses to the diaphragm.

MalaCards based summary: Respiratory System Benign Neoplasm is related to pleural lipoma and trachea leiomyoma. An important gene associated with Respiratory System Benign Neoplasm is MIR30C1 (MicroRNA 30c-1), and among its related pathways/superpathways are Disease and ESR-mediated signaling. Related phenotypes are Decreased viability and neoplasm

Sources

Related Diseases for Respiratory System Benign Neoplasm

Diseases related to Respiratory System Benign Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 515)

#	Related Disease	Score	Top Affiliating Genes
1	pleural lipoma	11.2
2	trachea leiomyoma	11.2
3	nasal cavity benign neoplasm	11.2
4	common bile duct neoplasm	10.5	KRAS HRAS
5	endometrial mucinous adenocarcinoma	10.4	KRAS CDKN2A
6	tonsillar pillar cancer	10.4	EGFR CDKN2A
7	hepatic flexure cancer	10.4	KRAS HRAS
8	trachea carcinoma in situ	10.4	KRAS HRAS CDKN2A
9	b-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	10.4	TP53 CDKN2A
10	liver angiosarcoma	10.4	TP53 KRAS HRAS
11	large cell carcinoma with rhabdoid phenotype	10.4	TP53 KRAS HRAS
12	pancreatic signet ring cell adenocarcinoma	10.4	TP53 KRAS HRAS
13	cervical basaloid squamous cell carcinoma	10.4	KRT7 CDKN2A
14	descending colon cancer	10.4	KRAS HRAS
15	larynx squamous papilloma	10.4	TP53 HRAS CDKN2A
16	thymus basaloid carcinoma	10.4	SYP NKX2-1
17	lung meningioma	10.4	SYP NKX2-1
18	differentiated thyroid carcinoma	10.4	NKX2-1 KRAS HRAS
19	subleukemic leukemia	10.4	SYP SCGB1A1
20	nasal cavity adenocarcinoma	10.4	KRT7 HRAS
21	ureter adenocarcinoma	10.4	NKX2-1 KRT7
22	adenosquamous lung carcinoma	10.4	KRAS HRAS EGFR
23	pancreatic foamy gland adenocarcinoma	10.4	TP53 KRT7
24	mismatch repair cancer syndrome	10.4	TP53 KRAS HRAS
25	mucinous bronchioloalveolar adenocarcinoma	10.4	NKX2-1 KRT7
26	acneiform dermatitis	10.4	KRAS HRAS EGFR
27	inverted transitional papilloma	10.4	KRT7 CDKN2A
28	alveoli adenoma	10.4	SFTPC SCGB1A1 NKX2-1
29	duodenal benign neoplasm	10.4	SYP HRAS
30	neonatal respiratory failure	10.4	SFTPC SCGB1A1 NKX2-1
31	myoma	10.4	TP53 KRAS EGFR
32	ampulla of vater benign neoplasm	10.4	SYP KRAS HRAS
33	bronchus adenoma	10.4	NKX2-1 NAPSA
34	bile duct mucinous adenocarcinoma	10.4	TP53 SYP
35	malignant spiradenoma	10.4	TP53 KRT7
36	paronychia	10.4	KRAS HRAS EGFR
37	atrophic vulva	10.4	KRT7 CDKN2A
38	vulvar sebaceous carcinoma	10.4	TP53 KRT7
39	bladder urachal carcinoma	10.4	KRT7 KRAS HRAS
40	urachus cancer	10.4	KRT7 KRAS HRAS
41	carotid body cancer	10.4	SYP NKX2-1
42	dermatopathia pigmentosa reticularis	10.4	KRAS HRAS EGFR
43	mucinous intrahepatic cholangiocarcinoma	10.4	KRT7 KRAS HRAS
44	sigmoid neoplasm	10.4	KRT7 KRAS HRAS
45	appendiceal neoplasm	10.4	KRT7 KRAS HRAS
46	vulvar eccrine porocarcinoma	10.4	SYP CDKN2A
47	thyroid tumor	10.4	KRAS HRAS AKT1
48	necrotizing sialometaplasia	10.4	TP53 KRT7
49	lung non-squamous non-small cell carcinoma	10.4	KRAS HRAS EGFR
50	esophagus verrucous carcinoma	10.4	TP53 EGFR CDKN2A

Graphical network of the top 20 diseases related to Respiratory System Benign Neoplasm:

Sources

Symptoms & Phenotypes for Respiratory System Benign Neoplasm

GenomeRNAi Phenotypes related to Respiratory System Benign Neoplasm according to GeneCards Suite gene sharing:

²⁵ (show all 12)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased viability	GR00055-A-1	9.78	EGFR HRAS KRAS
2	Decreased viability	GR00055-A-2	9.78	EGFR HRAS KRAS
3	Decreased viability	GR00055-A-3	9.78	KRAS
4	Decreased viability	GR00106-A-0	9.78	KRAS
5	Decreased viability	GR00221-A-1	9.78	AKT1 CDKN2A EGFR HRAS KRAS MYC
6	Decreased viability	GR00221-A-2	9.78	AKT1 HRAS KRAS
7	Decreased viability	GR00221-A-3	9.78	AKT1 CDKN2A HRAS MYC
8	Decreased viability	GR00221-A-4	9.78	AKT1 CDKN2A EGFR
9	Decreased viability	GR00249-S	9.78	AKT1 MYC
10	Decreased viability	GR00301-A	9.78	KRAS
11	Decreased viability	GR00381-A-1	9.78	KRAS
12	Decreased viability	GR00402-S-2	9.78	MYC

MGI Mouse Phenotypes related to Respiratory System Benign Neoplasm:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	neoplasm	MP:0002006	10	AKT1 CDKN2A DNAI7 EGFR HRAS KRAS
2	normal	MP:0002873	9.81	AKT1 EGFR HRAS KRAS MYC NKX2-1
3	pigmentation	MP:0001186	9.8	CDKN2A EGFR KRAS MLANA MYC TP53
4	no phenotypic analysis	MP:0003012	9.65	CDKN2A EGFR HRAS KRAS MIR30C1 MLANA
5	respiratory system	MP:0005388	9.28	AKT1 CDKN2A EGFR HRAS KRAS NKX2-1

Sources

Drugs & Therapeutics for Respiratory System Benign Neoplasm

Search Clinical Trials, NIH Clinical Center for Respiratory System Benign Neoplasm

Sources

Genetic Tests for Respiratory System Benign Neoplasm

Sources

Anatomical Context for Respiratory System Benign Neoplasm

Sources

Publications for Respiratory System Benign Neoplasm

Sources

Genes for Respiratory System Benign Neoplasm

Genes related to Respiratory System Benign Neoplasm (0 elite genes):

(show all 33)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	MIR30C1	MicroRNA 30c-1	RNA Gene	7	DISEASES inferred ¹⁴ ¹⁴
2	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	6.97	DISEASES inferred ¹⁴
3	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	6.96	DISEASES inferred ¹⁴
4	NKX2-1	NK2 Homeobox 1	Protein Coding	6.81	DISEASES inferred ¹⁴
5	TP53	Tumor Protein P53	Protein Coding	6.67	DISEASES inferred ¹⁴
6	SCGB1A1	Secretoglobin Family 1A Member 1	Protein Coding	6.3	DISEASES inferred ¹⁴
7	DNAI7	Dynein Axonemal Intermediate Chain 7	Protein Coding	6.3	DISEASES inferred ¹⁴
8	H2AC18	H2A Clustered Histone 18	Protein Coding	6.22	DISEASES inferred ¹⁴ ¹⁴
9	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	6.22	DISEASES inferred ¹⁴
10	MIR106B	MicroRNA 106b	RNA Gene	6.2	DISEASES inferred ¹⁴ ¹⁴
11	SFTPC	Surfactant Protein C	Protein Coding	6.17	DISEASES inferred ¹⁴
12	LMNTD1	Lamin Tail Domain Containing 1	Protein Coding	6.14	DISEASES inferred ¹⁴
13	IRAG2	Inositol 1,4,5-Triphosphate Receptor Associated 2	Protein Coding	6.07	DISEASES inferred ¹⁴
14	EGFR	Epidermal Growth Factor Receptor	Protein Coding	6.03	DISEASES inferred ¹⁴
15	NAPSA	Napsin A Aspartic Peptidase	Protein Coding	5.88	DISEASES inferred ¹⁴
16	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	5.75	DISEASES inferred ¹⁴
17	SYP	Synaptophysin	Protein Coding	5.72	DISEASES inferred ¹⁴
18	KRT7	Keratin 7	Protein Coding	5.7	DISEASES inferred ¹⁴
19	MYC	MYC Proto-Oncogene, BHLH Transcription Factor	Protein Coding	5.64	DISEASES inferred ¹⁴
20	MLANA	Melan-A	Protein Coding	5.62	DISEASES inferred ¹⁴
21	CCND1	Cyclin D1	Protein Coding	5.56	DISEASES inferred ¹⁴
22	PTEN	Phosphatase And Tensin Homolog	Protein Coding	5.51	DISEASES inferred ¹⁴
23	KRT5	Keratin 5	Protein Coding	5.35	DISEASES inferred ¹⁴
24	CTNNB1	Catenin Beta 1	Protein Coding	5.31	DISEASES inferred ¹⁴
25	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	5.27	DISEASES inferred ¹⁴
26	CD34	CD34 Molecule	Protein Coding	5.26	DISEASES inferred ¹⁴
27	ZNF251	Zinc Finger Protein 251	Protein Coding	5.25	DISEASES inferred ¹⁴
28	CHGA	Chromogranin A	Protein Coding	5.24	DISEASES inferred ¹⁴
29	TFE3	Transcription Factor Binding To IGHM Enhancer 3	Protein Coding	5.21	DISEASES inferred ¹⁴
30	TSC2	TSC Complex Subunit 2	Protein Coding	5.2	DISEASES inferred ¹⁴
31	BCL2	BCL2 Apoptosis Regulator	Protein Coding	5.19	DISEASES inferred ¹⁴
32	ACTB	Actin Beta	Protein Coding	5.18	DISEASES inferred ¹⁴
33	CDH1	Cadherin 1	Protein Coding	5.18	DISEASES inferred ¹⁴

Sources

Variations for Respiratory System Benign Neoplasm

Sources

Expression for Respiratory System Benign Neoplasm

Search GEO for disease gene expression data for Respiratory System Benign Neoplasm.

Sources

Pathways for Respiratory System Benign Neoplasm

Pathways related to Respiratory System Benign Neoplasm according to GeneCards Suite gene sharing:

(show top 50) (show all 66)

#	Super pathways	Score	Top Affiliating Genes
1	Disease ⁶⁶ Show member pathways Infectious disease ⁶⁶	13.82	TP53 SFTPC MYC KRAS HRAS H2AC18
2	ESR-mediated signaling ⁶⁶ Show member pathways Estrogen-dependent gene expression ⁶⁶ RUNX1 regulates estrogen receptor mediated transcription ⁶⁶ Signaling by Nuclear Receptors ⁶⁶	12.99	MYC KRAS HRAS H2AC18 EGFR AKT1
3	PI3K-Akt signaling pathway ⁷⁴ Show member pathways Focal adhesion: PI3K-Akt-mTOR-signaling pathway ⁷⁴	12.95	TP53 MYC KRAS HRAS EGFR AKT1
4	TNFR1 Pathway ⁶⁴ Show member pathways Apoptosis ⁷⁴ Apoptosis and survival TNFR1 signaling pathway ²² Apoptosis modulation by HSP70 ⁷⁴ Apoptosis through Death Receptors ⁶⁴ Apoptotic Pathways Triggered By HIV1 ⁶⁴ Ceramide signaling pathway ⁶¹ DR3 Signaling ⁶⁴ GITR Pathway ⁶⁴ HIV-1 Nef: Negative effector of Fas and TNF-alpha ⁶¹ Stimulation of the cell death response by PAK-2p34 ⁶⁶ TNF Signaling ⁶⁴ TNF-related weak inducer of apoptosis (TWEAK) signaling pathway ⁷⁴ TRAIL Pathway ⁶⁴ TWEAK Pathway ⁶⁴	12.94	TP53 MYC HRAS EGFR CDKN2A AKT1
5	Toll-like receptor signaling pathway ⁷⁴ Show member pathways Hepatitis B infection ⁷⁴ Measles virus infection ⁷⁴ Regulation of toll-like receptor signaling pathway ⁷⁴	12.86	TP53 MYC KRAS HRAS AKT1
6	Signaling by Receptor Tyrosine Kinases ⁶⁶	12.85	MYC KRAS HRAS EGFR AKT1
7	Pre-NOTCH Expression and Processing ⁶⁶ Show member pathways Defective LFNG causes SCDO3 ⁶⁶ Pre-NOTCH Processing in Golgi ⁶⁶ Pre-NOTCH Processing in the Endoplasmic Reticulum ⁶⁶ Pre-NOTCH Transcription and Translation ⁶⁶ Signaling by NOTCH ⁶⁶	12.78	TP53 MYC H2AC18 EGFR AKT1
8	G-Beta Gamma Signaling ⁶⁴ Show member pathways CRHR Pathway ⁶⁴ GHRH Signaling ⁶⁴	12.67	KRAS HRAS EGFR CDKN2A AKT1
9	4-1BB Pathway ⁶⁴ Show member pathways CD27 Pathway ⁶⁴ CD40 Signaling ⁶⁴ CMV and MAPK Pathways ⁶⁴ NF-KappaB Activation by EBV ⁶⁴ NF-kappaB Activation by Viruses ⁶⁴ PKR Pathway ⁶⁴ SUMO Pathway ⁶⁴ TNFR2 Pathway ⁶⁴	12.67	TP53 KRAS HRAS EGFR AKT1
10	Malignant pleural mesothelioma ⁷⁴	12.65	TP53 MYC HRAS EGFR CDKN2A AKT1
11	Overview of interferons-mediated signaling pathway ⁷⁴ Show member pathways all-trans-Retinoic Acid Mediated Apoptosis ⁶⁴ Cytokine Network ⁶⁴ Immune response IFN alpha/beta signaling pathway ²² Interferon alpha/beta signaling ⁶⁶ Jak/STAT Signaling Pathway ⁶⁵ Regulation of IFNA/IFNB signaling ⁶⁶ Type III interferon signaling ⁷⁴	12.62	TP53 MYC KRAS HRAS EGFR AKT1
12	Immune response IL-23 signaling pathway ²² Show member pathways Angiopoietin receptor Tie2-mediated signaling ⁶¹ Angiopoietin-TIE2 Signaling ⁶⁴ Development Angiopoietin - Tie2 signaling ²² Development PDGF signaling via STATs and NF-kB ²² IL23-mediated signaling events ⁶¹ Immune response IL-10 signaling pathway ²² RAC1/PAK1/p38/MMP2 pathway ⁷⁴	12.54	TP53 MYC KRAS HRAS EGFR AKT1
13	Endometrial cancer ⁷⁴ Show member pathways Chromosomal and microsatellite instability in colorectal cancer ⁷⁴ Melanoma ⁷⁴ Non-small cell lung cancer ⁷⁴ Pancreatic adenocarcinoma pathway ⁷⁴ Signal transduction PTEN pathway ²²	12.49	TP53 MYC KRAS HRAS EGFR CDKN2A
14	Development Dopamine D2 receptor transactivation of EGFR ²² Show member pathways Chemotaxis CXCR4 signaling pathway ²² Development Alpha-2 adrenergic receptor activation of ERK ²² Extra-nuclear estrogen signaling ⁶⁶	12.42	KRAS HRAS EGFR AKT1
15	NF-kappaB Pathway ⁷⁰ Show member pathways Akt Pathway ⁷⁰ Apoptosis Pathway ⁷⁰	12.42	TP53 KRAS HRAS EGFR AKT1
16	Breast cancer pathway ⁷⁴ Show member pathways Embryonic stem cell pluripotency pathways ⁷⁴	12.37	TP53 MYC KRAS HRAS EGFR AKT1
17	Development EGFR signaling pathway ²² Show member pathways Development ERBB-family signaling ²² EGF Pathway ⁶⁴ EGFR Signaling Pathway ⁶⁷ ErbB receptor signaling network ⁶¹	12.33	AKT1 EGFR HRAS KRAS MYC TP53
18	Development IGF-1 receptor signaling ²² Show member pathways Immune response IL-4 signaling pathway ²² Signal transduction AKT signaling ²²	12.27	TP53 MYC HRAS AKT1
19	MAPK signaling pathway ⁷⁴	12.27	TP53 MYC KRAS HRAS EGFR AKT1
20	Ras signaling ⁷⁴	12.26	KRAS HRAS EGFR AKT1
21	VEGF Signaling Pathway ⁶⁰ ⁶⁷ Show member pathways Nanoparticle-mediated activation of receptor signaling ⁷⁴ TGF-beta Signaling ⁶⁷	12.23	KRAS HRAS EGFR AKT1
22	Epithelial to mesenchymal transition in colorectal cancer ⁷⁴	12.19	AKT1 HRAS KRAS TP53
23	Signaling by PTK6 ⁶⁶ Show member pathways PTK6 Activates STAT3 ⁶⁶ PTK6 Down-Regulation ⁶⁶ PTK6 Expression ⁶⁶ PTK6 promotes HIF1A stabilization ⁶⁶ PTK6 Regulates Proteins Involved in RNA Processing ⁶⁶ PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases ⁶⁶ PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 ⁶⁶ Signaling by Non-Receptor Tyrosine Kinases ⁶⁶	12.16	KRAS HRAS EGFR AKT1
24	Colorectal Cancer Metastasis ⁶⁴	12.16	TP53 MYC KRAS EGFR AKT1
25	MAPK Signaling: Mitogens ⁶⁵ Show member pathways Akt Signaling Pathway ⁶⁵	12.16	TP53 MYC KRAS HRAS EGFR AKT1
26	T-cell activation SARS-CoV-2 ⁷⁴ Show member pathways T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection ⁷⁴	12.15	TP53 HRAS CDKN2A AKT1
27	NGF Pathway ⁶⁴ Show member pathways MAPK and NFkB signaling pathways inhibited by Yersinia YopJ ⁷⁴ TRKA Signaling ⁶⁴	12.13	AKT1 HRAS KRAS MYC TP53
28	mTOR Signaling ⁶⁵	12.09	TP53 KRAS EGFR AKT1
29	Integrated breast cancer pathway ⁷⁴	12.09	TP53 MYC KRAS EGFR AKT1
30	Signaling by ERBB2 ⁶⁶ Show member pathways Downregulation of ERBB2 signaling ⁶⁶ Downregulation of ERBB2:ERBB3 signaling ⁶⁶ ERBB2 Activates PTK6 Signaling ⁶⁶ ERBB2 Regulates Cell Motility ⁶⁶ GRB7 events in ERBB2 signaling ⁶⁶	12.04	KRAS HRAS EGFR AKT1
31	DNA damage response (only ATM dependent) ⁷⁴	11.9	TP53 MYC KRAS HRAS
32	Development EGFR signaling via small GTPases ²² Show member pathways Development EGFR signaling via PIP3 ²² Development PDGF signaling via MAPK cascades ²²	11.88	MYC KRAS HRAS EGFR AKT1
33	VEGF Pathway (Tocris) ⁷⁰ Show member pathways Sorafenib Pharmacodynamics ⁶⁰	11.8	KRAS HRAS AKT1
34	Regulation of TP53 Expression and Degradation ⁶⁶ Show member pathways Regulation of TP53 Degradation ⁶⁶ Regulation of TP53 Expression ⁶⁶	11.77	AKT1 CDKN2A TP53
35	mTOR Pathway ⁷⁰ Show member pathways TGF-beta Pathway ⁷⁰	11.77	TP53 KRAS HRAS AKT1
36	AP-1 transcription factor network ⁶¹	11.73	TP53 MYC CDKN2A
37	Regulation of Telomerase ⁶¹	11.73	MYC EGFR AKT1
38	miRNAs involved in DNA damage response ⁷⁴	11.72	TP53 MYC MIR106B
39	Physico-chemical features and toxicity-associated pathways ⁷⁴	11.7	MYC EGFR AKT1
40	Pathways affected in adenoid cystic carcinoma ⁷⁴	11.68	TP53 HRAS AKT1
41	Gastrin signaling pathway ⁷⁴	11.68	MYC KRAS HRAS EGFR CDKN2A AKT1
42	BDNF-TrkB signaling ⁷⁴ Show member pathways Synaptic signaling pathways associated with autism spectrum disorder ⁷⁴	11.66	KRAS HRAS AKT1
43	Agrin Interactions at Neuromuscular Junction ⁶⁴	11.63	EGFR HRAS KRAS
44	IL-2 Gene Expression in Activated and Quiescent T-Cells ⁶⁴ Show member pathways TOB in T-Cell Signaling ⁶⁴	11.62	MYC HRAS EGFR AKT1
45	Hepatitis C and hepatocellular carcinoma ⁷⁴	11.61	TP53 MYC AKT1
46	p53 pathway ⁶¹	11.57	TP53 CDKN2A AKT1
47	LPA receptor mediated events ⁶¹	11.53	HRAS EGFR AKT1
48	Kisspeptin/kisspeptin receptor system in the ovary ⁷⁴	11.42	KRAS HRAS AKT1
49	Integrated cancer pathway ⁷⁴	11.41	TP53 MYC AKT1
50	Crizotinib Pathway, Pharmacokinetics/Pharmacodynamics ⁶⁰	11.41	KRAS HRAS AKT1

Sources

GO Terms for Respiratory System Benign Neoplasm

Cellular components related to Respiratory System Benign Neoplasm according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	alveolar lamellar body	GO:0097208	8.92	SFTPC NAPSA

Biological processes related to Respiratory System Benign Neoplasm according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	MAPK cascade	GO:0000165	9.97	MYC KRAS HRAS EGFR
2	cell population proliferation	GO:0008283	9.8	TP53 LMNTD1 KRAS EGFR AKT1
3	Ras protein signal transduction	GO:0007265	9.76	CDKN2A HRAS KRAS TP53
4	positive regulation of gene expression	GO:0010628	9.73	TP53 NKX2-1 MYC KRAS HRAS CDKN2A
5	response to UV-A	GO:0070141	9.62	EGFR AKT1
6	regulation of long-term neuronal synaptic plasticity	GO:0048169	9.1	SYP KRAS HRAS

Sources

Sources for Respiratory System Benign Neoplasm

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: RSP004 MIFTS: 27	Respiratory System Benign Neoplasm Categories: Cancer diseases, Respiratory diseases	Data Licensing For inquiries, contact: [email protected]
Genes Related diseases Expand all tables